Evidence that Drives Decisions: Health Technology Assessment (HTA) for Horizon Europe

Consorzio Italbiotec provides expert support in Health Technology Assessment (HTA) within Health projects, helping consortia generate robust evidence to support clinical relevance, economic value and societal impact of health innovations. Our HTA services are designed to strengthen both project implementation and impact sections, through early and parallel HTA approaches that guide technology development. Activities include the assessment of clinical effectiveness, safety and comparative value, health economic analyses and cost-effectiveness considerations, as well as the evaluation of organisational, ethical and social implications of health technologies. By integrating HTA methodologies from the early stages of R&I projects, Consorzio Italbiotec supports the alignment of innovations with healthcare system needs, payer expectations and regulatory frameworks, enabling evidence-based decision-making and facilitating future adoption, reimbursement and scale-up. All HTA activities are aligned with EU HTA principles, Horizon Europe impact requirements and patient-centred innovation approaches, ensuring relevance for decision-makers, healthcare providers and policy stakeholders.

📩 We are interested in collaborating with companies and research organisations seeking HTA expertise to strengthen the credibility, uptake potential and long-term impact of their health projects.